Press Release

11월 14, 2024

DSM-Firmenich AG to sell part of its stake in Robertet S.A.

보도 자료 금융 및 규제 뉴스 2024

인쇄

Kaiseraugst (Switzerland), Maastricht (Netherlands), November 14, 2024

dsm-firmenich today announces that it has successfully concluded a new €1.8 billion revolving credit facility (RCF) to replace existing RCF arrangements which expire in 2025: DSM’s €1 billion RCF and Firmenich’s CHF750 million RCF.

The syndicated facility, which dsm-firmenich entered into with a group of 15 banks, has a tenor of five years and two one-year extension options. In addition, the facility is available for general corporate purposes of the Group.

The new RCF is a strong pillar in the Group’s financing strategy. It helps to centralize and streamline dsm-firmenich’s financing structure, and it underpins the group’s financial flexibility. The transaction also confirms the strong relationship dsm-firmenich has with its international and regional financial partners.

 

PDF version of this press release can be found on this link

 

 

For more information:

Media relations:
e-mail: media@dsm-firmenich.com 

Investor relations:
e-mail: investors@dsm-firmenich.com

About dsm-firmenich

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. www.dsm-firmenich.com

Disclaimer


This press release does not constitute or form part of, an offer or any solicitation of an offer for securities in any jurisdiction. This communication is not for release, distribution or publication, whether directly or indirectly and whether in whole or in part, into or in the United States of America or any (other) jurisdiction where any of such activities would constitute a violation of the relevant laws of such jurisdiction.

The offer of bonds referred to in this communication was limited in the EEA and the United Kingdom to qualified investors only. The bonds have not been and will not be registered under the US Securities Act of 1933, as amended (the “US Securities Act”) and will also not be registered with any authority competent with respect to securities in any state or other jurisdiction of the United States of America. The bonds may not be offered or sold in the United States of America without either registration of the securities or an exemption from registration under the US Securities Act being applicable.

The English language version of this press release prevails over other language versions.

번역 면책 조항 이 페이지는 AI를 사용하여 자동 번역되었습니다. 정확성을 목표로 하지만, 번역이 완벽하지 않거나 원본 내용을 잘못 해석할 수 있습니다. 중요한 정보는 원본 언어 버전을 참조해 주시기 바랍니다. AI 번역은 사용자의 재량에 따라 사용하시기 바랍니다. DSM‑Firmenich는 이러한 번역으로 인해 발생하는 오류나 오해에 대해 책임을 지지 않습니다.